Obalon Therapeutics, Inc. (NASDAQ:OBLN)
Industry: Healthcare

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.

Current Quote*
Last: $4.261
Change: 1.000
Book: $3.026
Volume: 6,261,294

As Of: 06/15 13:00 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol OBLN

  • No BuyIns.Net Alerts Available for OBLN

Graphs for OBLN


3 Month Graph


6 Month Graph


1 Year Graph